PTK2 and esophageal squamous cell carcinoma: In summary, we used in vitro and in vivo models to reveal that miR-92b suppressed invasion-metastasis cascade of ESCC cells by inhibiting ITGAV-FAK-Rac1 pathway, providing a promise in diagnosis and treatment of ESCC.